However, although we found enrichment of KLRG1 on circulating tumor-TCR-matching cytotoxic CD4+ T cells, the functional relevance of this ligand-receptor interaction for tumor recognition and killing in this subset has not been studied. Here, KLRG1 is linked to neoplasm.